These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 19499845

  • 1. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
    Costantino D, Minozzi G, Minozzi E, Guaraldi C.
    Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
    [Abstract] [Full Text] [Related]

  • 2. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G.
    N Engl J Med; 1999 Apr 29; 340(17):1314-20. PubMed ID: 10219066
    [Abstract] [Full Text] [Related]

  • 3. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.
    Gerli S, Papaleo E, Ferrari A, Di Renzo GC.
    Eur Rev Med Pharmacol Sci; 2007 Apr 29; 11(5):347-54. PubMed ID: 18074942
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
    Gerli S, Mignosa M, Di Renzo GC.
    Eur Rev Med Pharmacol Sci; 2003 Apr 29; 7(6):151-9. PubMed ID: 15206484
    [Abstract] [Full Text] [Related]

  • 6. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
    Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A.
    Gynecol Endocrinol; 2007 Dec 29; 23(12):700-3. PubMed ID: 17952759
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
    Zacchè MM, Caputo L, Filippis S, Zacchè G, Dindelli M, Ferrari A.
    Gynecol Endocrinol; 2009 Aug 29; 25(8):508-13. PubMed ID: 19551544
    [Abstract] [Full Text] [Related]

  • 8. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
    Regidor PA, Schindler AE, Lesoine B, Druckman R.
    Horm Mol Biol Clin Investig; 2018 Mar 02; 34(2):. PubMed ID: 29498933
    [Abstract] [Full Text] [Related]

  • 9. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R.
    Clin Pharmacol Ther; 2006 Aug 02; 80(2):105-14. PubMed ID: 16890572
    [Abstract] [Full Text] [Related]

  • 10. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.
    Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G, Nestler JE.
    Endocr Pract; 2002 Aug 02; 8(6):417-23. PubMed ID: 15251831
    [Abstract] [Full Text] [Related]

  • 11. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.
    Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V.
    Gynecol Endocrinol; 2013 Apr 02; 29(4):375-9. PubMed ID: 23336594
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.
    Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F.
    Eur Rev Med Pharmacol Sci; 2011 May 02; 15(5):509-14. PubMed ID: 21744744
    [Abstract] [Full Text] [Related]

  • 14. The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome.
    Minozzi M, Costantino D, Guaraldi C, Unfer V.
    Gynecol Endocrinol; 2011 Nov 02; 27(11):920-4. PubMed ID: 21417594
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B, Flyvbjerg A, Kesmodel U, Lauszus FF.
    Hum Reprod; 2007 Nov 02; 22(11):2967-73. PubMed ID: 17766923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A, Laganà AS, Barbaro L.
    Gynecol Endocrinol; 2014 Mar 02; 30(3):205-8. PubMed ID: 24351072
    [Abstract] [Full Text] [Related]

  • 19. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial.
    Kilicdag EB, Bagis T, Tarim E, Aslan E, Erkanli S, Simsek E, Haydardedeoglu B, Kuscu E.
    Hum Reprod; 2005 Jun 02; 20(6):1521-8. PubMed ID: 15790610
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.